The NIH Division of Biologics Standards (DBS) licensed the rubella vaccine for use in June 1969. Explore this selection of items from the NLM Digital Collections to discover how scientists working at the DBS set policy, conducted research, and enforced standards to ensure the safety of vaccines.
“Rubella vaccine licensed, virus strain developed by scientists at NIH,” The NIH Record, Bethesda, Maryland, June 24, 1969
Courtesy National Library of Medicine
The NIH Record announced that DBS issued the pharmaceutical company Merck Sharp & Dohme the first license to produce a rubella vaccine in June 1969. The vaccine was based on the work of Parkman and Meyer at the NIH.